Thermo Fisher Scientific

+$6.24 (+1.17%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TMO and other ETFs, options, and stocks.

About TMO

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

CEO
Marc N. Casper
Employees
80,000
Headquarters
Waltham, Massachusetts
Founded
1960

TMO Key Statistics

Market Cap
212.24B
Price-Earnings Ratio
25.02
Dividend Yield
0.18
Average Volume
1.16M
High Today
$543.30
Low Today
$531.38
Open Price
$532.91
Volume
1.41M
52 Week High
$543.30
52 Week Low
$401.07

TMO News

Simply Wall StJul 29

Introducing Thermo Fisher Scientific, The Stock That Zoomed 239% In The Last Five Years

When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really flourishing, you can make more than 100%.
BenzingaJul 28

Thermo Fisher Scientific: Q2 Earnings Insights

Shares of Thermo Fisher Scientific (NYSE:TMO) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share rose 43.96% over
ReutersJul 28

UPDATE 3-Thermo Fisher cuts 2021 COVID-19 test sales forecast by $900 mln, citing lower demand

(Adds CEO, analyst comments) By Amruta Khandekar July 28 (Reuters) - Thermo Fisher Scientific Inc on Wednesday raised its full-year revenue outlook, but cut i

TMO Earnings

$2.79
$4.26
$5.74
$7.21
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
$5.49 per share
Actual
$5.60 per share
Replay Earnings Call

More TMO News

ReutersJul 28

UPDATE 1-Thermo Fisher raises 2021 outlook on strong COVID-19 services demand

(Adds forecast, background) July 28 (Reuters) - Thermo Fisher Scientific Inc raised its full-year 2021 outlook, boosted by revenue from its life sciences unit
ReutersJul 28

Thermo Fisher profit beats estimates on COVID-19 services demand

(Reuters) -Thermo Fisher Scientific Inc’s second-quarter profit beat expectations on Wednesday, boosted by its unit which makes raw materials for COVID-19 vacci
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure